Barcelona-based venture capital firm Nina Capital has announced the first close of its €50 million Fund III. This new fund brings their total assets under management to over €100 million. Fund III has attracted contributions from limited partners, including Boston-based wealth management firm Seven Two Partners, professional family offices, foundations, corporations, and individuals from Europe and the United States.
Dr. Marta G. Zanchi, Founder and Managing Director, expressed enthusiasm about the fund’s potential, stating, “Healthcare is at an inflection point.
We see extraordinary opportunities for innovation to break down inefficiencies, increase access, and improve outcomes. Fund III solidifies our commitment to finding and supporting the boldest minds tackling healthcare’s most urgent challenges.”
Founded in 2019 by Dr. Marta G.
Zanchi, the firm plans to build a new portfolio of investments across Europe, North America, Israel, and, for the first time, Australia with Fund III.
Fund III’s new market expansion
The fund will make initial investments ranging from €250k to €1.5 million, with reserves for follow-on funding to support portfolio companies.
They have already announced their first Fund III investment in Sonar Mental Health, a US-based platform offering AI and human-led mental health support to school districts nationwide. According to Dr. Zanchi, startups from Fund I achieved an above 80% graduation rate from seed to the next stage, while Fund II portfolio companies saw nearly a 5x revenue growth within two years from the initial investment.
Dr. Marta G. Zanchi, who previously directed Stanford Biodesign’s Digital Health initiatives, and Marc Subirats, a seasoned entrepreneur whose telemedicine company Advance Medical was acquired by Teladoc Health, bring relevant experience to their roles as General Partners.
Andrew Macken, Managing Partner at Seven Two Partners, emphasized the importance of innovative leadership in healthcare, stating, “For the best outcomes in this complex industry, we believe that it is important for managers to find great founders who are working on solving significant problems and for those managers to help these businesses grow. We are impressed with the work that Marta and her team have accomplished and excited to see what they have in store to reshape the future of healthcare.”
Fund III will focus on three critical healthtech areas: Clinical Innovation and Education, Healthcare Infrastructure, and Clinical Pathways and Health Data. These areas aim to empower new solutions in diagnostics, medical devices, clinician training, transform data-driven processes in preclinical R&D, clinical trials, pharmaceutical logistics, and manufacturing, and improve care delivery through tech-enabled services and operational efficiencies.
The firm continues to demonstrate its leadership in driving healthcare innovation, leveraging its extensive expertise and strategic partnerships to create impactful and measurable healthcare solutions.
